When 'Just Stress' Might Be Your Immune System: Signs Your Doctor Should Check

The average person who ends up with an autoimmune disease diagnosis sees four different doctors over the course of four years before anyone names what’s wrong. Nearly a third of patients report that the process took more than a decade from the point they started seeking help. And 96% received at least one misdiagnosis along the way, with 36% being told their symptoms were psychosomatic, “all in your head,” or attributable to stress.

Those numbers come from patient survey data compiled by the American Autoimmune Related Diseases Association. They paint a picture that’s grimly familiar to anyone who’s lived through it: you know something is wrong, you can’t prove it with a single test, and the medical system keeps shrugging. Young adults, and young women above all, bear the worst of this pattern. A 2019 Lancet analysis confirmed that female patients with subtle or nonspecific symptoms are more likely to have their complaints attributed to mental health concerns, stress, or hormonal fluctuations rather than investigated for underlying autoimmune activity.

The frustrating part is that family doctors have access to straightforward screening tools that can flag autoimmune problems early. The gap isn’t in the tests. It’s in knowing when to order them and in patients knowing what to ask for. That’s what this article is about.

The Numbers Are Moving in the Wrong Direction

Autoimmune diseases now affect an estimated 5-8% of the population in high-income countries, and the trend line is climbing. A 2023 study in The Lancet, covering 22 million individuals in the UK, documented the rising incidence and prevalence of autoimmune conditions across age groups, with sharp increases in younger populations. Type 1 diabetes prevalence has nearly doubled over 40 years. Celiac disease incidence has increased fivefold in 30 years. Multiple sclerosis cases worldwide rose 30% between 2013 and 2022. Canada reports the highest incidence of Crohn’s disease in the world.

The biomarker data tells a parallel story. Antinuclear antibodies, or ANA, are the most common blood marker of autoimmune activity. NIH researchers tracking ANA prevalence in the US population found that positivity rates among adolescents rose from 11% in 1988-1991 to 15.9% by 2011-2012. That shift represents millions of additional people whose immune systems are showing signs of self-directed activity, even if most will never develop a diagnosable autoimmune disease. Something in our environment, our diets, or our microbial exposures is priming immune systems to behave differently than they did a generation ago.

What’s driving the rise? The honest answer is that no one has identified a single cause, but several factors carry strong evidence. The gut microbiome sits at the center of most current research. Patients with autoimmune conditions from multiple sclerosis to rheumatoid arthritis to lupus show distinct gut microbiota compositions compared to healthy controls, and the pattern holds across study after study. A 2024 review in Immunological Reviews by researchers at the forefront of microbiome-immunity research mapped the connections between gut bacteria, mucosal immunity, and the triggering of autoimmune responses at distant body sites. The emerging picture is that disruptions in gut ecology, driven by diet, antibiotics, environmental exposures, or some combination, can shift the immune system toward self-attack in genetically susceptible individuals.

Ultra-processed food is drawing particular scrutiny. A 2025 analysis in Nutrients documented how these foods, high in synthetic additives, emulsifiers, and refined ingredients, reduce microbial diversity and lower levels of beneficial bacteria like Akkermansia muciniphila and Faecalibacterium prausnitzii. Those aren’t obscure organisms. They’re keystone species that maintain gut barrier integrity and produce short-chain fatty acids that regulate immune function. When they decline, intestinal permeability increases, and immune cells encounter bacterial products they shouldn’t be seeing. The inflammatory cascade that follows can, in the right genetic context, become self-sustaining. This is one of the places where the early-onset colon cancer story and the autoimmune story converge on the same science [see: Colon Cancer Under 45: What Your Family Doctor Can Actually Do].

What Gets Dismissed as “Normal”

The hallmark of early autoimmune disease is that individual symptoms are common and nonspecific. Fatigue, joint pain, brain fog, digestive issues, skin problems, hair thinning. Any one of them could plausibly be stress, poor sleep, aging, a viral infection that’s lingering, or nothing. What distinguishes autoimmune-related symptoms from the everyday version is their persistence, their severity relative to obvious causes, and their tendency to cluster.

Autoimmune fatigue doesn’t improve with rest. That’s the most commonly cited distinguishing feature in clinical literature, and it holds up well in practice. The person who sleeps nine hours, wakes up exhausted, pushes through a workday on willpower, and crashes every evening is describing something qualitatively different from someone who’s tired because they stayed up too late. When that fatigue pairs with unexplained joint stiffness that’s worse in the morning and improves with movement, or with new skin changes (rashes that come and go, particularly across the cheeks or on sun-exposed areas), or with GI symptoms that don’t respond to typical dietary adjustments, the pattern starts to coalesce.

Most autoimmune diseases are diagnosed between ages 20 and 50. That means young adults are squarely in the window, and the symptoms often begin in the 20s or early 30s, at exactly the life stage when people are most likely to attribute everything to being busy, stressed, or out of shape. The danger isn’t paranoia. It’s passivity. Not every instance of fatigue needs an autoimmune workup. But fatigue that’s been dragging on for months, that doesn’t correlate with your sleep or stress levels, and that comes with one or two other symptoms on this list? That deserves more than a shrug and a suggestion to get more exercise.

Tests Your Family Doctor Can Order Today

The good news is that the initial autoimmune screening panel is simple, cheap, and available at any Ontario lab with a standard requisition. Here’s what each test does and what the results actually mean.

ANA (Antinuclear Antibody): This is the most commonly ordered autoimmune screening test, and it’s also the most misunderstood. A positive ANA means your immune system is producing antibodies directed against your own cell nuclei. It does not mean you have an autoimmune disease. Between 15% and 20% of perfectly healthy adults will test positive, especially at low titers. The test is sensitive but not specific, meaning it catches most people with certain autoimmune diseases (lupus, scleroderma, Sjogren’s) but also flags many people who don’t have them. Your doctor should never order an ANA out of curiosity. It should follow a clinical evaluation that found suspicious symptoms, because interpreting a positive result without clinical context creates anxiety without useful information. A positive ANA at high titer with matching symptoms warrants referral to a rheumatologist. A positive ANA at low titer in someone with no symptoms warrants monitoring, not alarm.

TSH (Thyroid-Stimulating Hormone): Hashimoto’s thyroiditis is the most common autoimmune disease in North America, and it’s diagnosed with a simple blood test. An elevated TSH indicates an underactive thyroid, which is the usual end result of Hashimoto’s. If your TSH is abnormal, your doctor can add thyroid antibody tests (anti-TPO, anti-thyroglobulin) to confirm whether the cause is autoimmune. For more on thyroid conditions specifically, we’ve covered the topic in detail [see: When ‘Just Stress’ Might Be Your Thyroid: What Bluetooth Ultrasound Can Actually See].

CRP and ESR (C-Reactive Protein and Erythrocyte Sedimentation Rate): These are general inflammation markers. They don’t tell you what’s inflamed or why, but they’re useful for establishing whether systemic inflammation is present. Normal levels in someone with vague symptoms are reassuring. Elevated levels warrant further investigation. They’re also useful for monitoring disease activity over time once a diagnosis is established.

Celiac Panel (tTG-IgA): Celiac disease has increased fivefold in prevalence over 30 years and remains massively underdiagnosed. The screening test is a single blood draw. If you have persistent GI symptoms, unexplained iron deficiency, chronic fatigue, or a first-degree relative with celiac disease, this test is worth requesting. The Canadian Celiac Association estimates that for every diagnosed celiac patient, there are several more who haven’t been identified.

CBC (Complete Blood Count): Not an autoimmune test per se, but it catches anemia (which accompanies many autoimmune conditions), abnormal white blood cell counts, and low platelets, all of which can be early indicators that something immunological is happening. It’s part of standard baseline bloodwork [see: The Bloodwork You’ve Been Meaning to Get] and costs nothing extra on a routine lab requisition.

None of these tests in isolation confirms or rules out autoimmune disease. That’s the nature of conditions where the diagnosis depends on the pattern of symptoms, lab findings, and sometimes imaging or biopsy results. But collectively, they give your family doctor a solid foundation for deciding whether to monitor, investigate further, or refer to a specialist. The key is getting them ordered in the first place.

When Family History Changes the Math

Autoimmune diseases cluster in families, but not in the way most people expect. If your mother has rheumatoid arthritis, your personal risk isn’t specifically for rheumatoid arthritis. It’s elevated for autoimmune disease in general. The genetic architecture is shared: HLA genes, certain class I and class II variants in specific, show up across celiac disease, rheumatoid arthritis, type 1 diabetes, autoimmune thyroid disease, and lupus. Cytokine-related genes like IL2 and IL21, which influence how aggressively the immune system responds, connect these conditions at a molecular level.

What this means practically is that your family health history deserves careful attention. If one first-degree relative has an autoimmune condition, your baseline risk is elevated enough to justify proactive screening when you have symptoms that might otherwise be dismissed. If multiple relatives across the family tree have autoimmune conditions, even different ones, the genetic loading is real and worth discussing with your doctor. A 2025 review recommended that individuals with autoimmune-linked gene variants, identified either through family history or genetic testing, should have monitoring plans that include baseline immune assessments, targeted lab work, and specialist follow-ups at intervals matched to their risk profile.

Bring the information. Write down what your parents, siblings, and grandparents have been diagnosed with. Include thyroid disease, type 1 diabetes, celiac, IBD, psoriasis, lupus, and rheumatoid arthritis. Mention conditions that were never formally diagnosed but fit the pattern: the aunt who was always exhausted and had joint pain that nobody could explain, the father with persistent skin issues that came and went. This kind of context is exactly what a family doctor needs to shift from reactive care to proactive screening, and it’s something that gets lost in walk-in clinic visits [see: The Doctor Visit You Keep Putting Off: What Actually Happens at an Annual Physical] where nobody is tracking your story across time.

What You Can Do Before Your Appointment

The modifiable risk factor evidence for autoimmune disease is less precise than for conditions like heart disease or colorectal cancer, but the direction is consistent. Vitamin D deficiency is implicated in multiple sclerosis risk and shows up repeatedly in autoimmune research. Smoking is a strong, dose-dependent risk factor for rheumatoid arthritis and lupus. The gut microbiome evidence, while still being refined, points repeatedly toward fiber-rich diets, limited ultra-processed food, and diverse food sources as protective. None of this is a cure, and nothing you eat will override a strong genetic predisposition. But the environmental factors that appear to trigger autoimmune disease in susceptible people are, in many cases, the same lifestyle factors that protect against metabolic disease, cardiovascular disease, and colorectal cancer [see: Colon Cancer Under 45: What Your Family Doctor Can Actually Do]. The biology converges.

If you’re reading this because you have a cluster of symptoms that won’t go away and no one has been able to explain, the most important thing you can do is find a family doctor who will take the time to listen. Not a five-minute visit. A real conversation about what you’ve been experiencing, how long it’s been happening, and what runs in your family. Ask for the basic screening panel described above. If the results come back normal, that’s good news, and your doctor can set a plan for monitoring if your symptoms persist. If something flags, you’ll have a direction. Either way, you’ll be further along than the average autoimmune patient who spent four years and four doctors getting nowhere.

That conversation is worth having. And it’s exactly the kind of conversation that works best with a doctor who already knows you.

---

References

1. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: population-based cohort study of 22 million individuals in the UK. The Lancet, 2023. DOI: 10.1016/S0140-6736(23)00457-9 thelancet.com/journals/lancet/article/PIIS0140-6736(23)00457-9/abstract

2. Autoimmunity may be rising in the United States. National Institutes of Health, 2024. nih.gov/news-events/news-releases/autoimmunity-may-be-rising-united-states

3. The Modern Epidemic of Autoimmunity. International Journal of Rheumatic Diseases, 2024. DOI: 10.1111/1756-185X.15426 onlinelibrary.wiley.com/doi/full/10.1111/1756-185X.15426

4. Autoimmunity and the microbiome. Immunological Reviews, 2024. DOI: 10.1111/imr.13363 onlinelibrary.wiley.com/doi/full/10.1111/imr.13363

5. The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier. Nutrients, 2025. DOI: 10.3390/nu17050859 mdpi.com/2072-6643/17/5/859

6. The impact of the gut microbiome on extra-intestinal autoimmune diseases. Nature Reviews Immunology, 2022. DOI: 10.1038/s41577-022-00727-y nature.com/articles/s41577-022-00727-y

7. Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in adolescents and young adults (15-39 years): GBD 2021. PMC, 2024. PMC11227207 pmc.ncbi.nlm.nih.gov/articles/PMC11227207/

8. Gender Bias and Diagnostic Delays in Young Women: A Narrative Review. Cureus, 2025. PMC12829432 pmc.ncbi.nlm.nih.gov/articles/PMC12829432/

9. Estimation of prevalence of autoimmune diseases in the United States using electronic health record data. Journal of Clinical Investigation, 2025. DOI: 10.1172/JCI178722 jci.org/articles/view/178722

10. The Increasing Prevalence of Autoimmunity and Autoimmune Diseases: An Urgent Call to Action. Current Opinion in Immunology, 2023. PMC9918670 pmc.ncbi.nlm.nih.gov/articles/PMC9918670/

11. Temporal Trend and Health Inequality in the Burden of Autoimmune Diseases Among Older Adolescents and Young Adults Aged 15-29. PMC, 2025. PMC12502848 pmc.ncbi.nlm.nih.gov/articles/PMC12502848/